Literature DB >> 31028762

YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis.

Tingting Yang1, Fanglin Shu1, Hao Yang1, Cai Heng1, Yi Zhou1, Yibing Chen1, Xuan Qian1, Lei Du1, Xia Zhu1, Qian Lu1, Xiaoxing Yin2.   

Abstract

BACKGROUND: Renal fibrosis promotes the development of diabetic nephropathy (DN). A growing number of studies have reported that Yin Yang 1 (YY1), which is involved in cellular proliferation and differentiation, plays a crucial role in the pathogenesis of many diseases, such as pulmonary fibrosis, hepatic steatosis and cancer.
METHODS: We detected the expression of YY1 under various glucose concentration and time gradient conditions. Rapamycin was used to verify the mTORC1/p70S6K/YY1 signaling pathway in HK-2 cells. We used db/db mice to examine the connection between renal fibrosis and YY1. A luciferase assay and chromatin immunoprecipitation (ChIP) assay were used to identify whether YY1 directly regulated α-SMA by binding to the α-SMA promoter. RNA silencing and overexpression were performed by using a YY1 expression/knockdown plasmid to investigate the function of YY1 in renal fibrosis of DN.
RESULTS: YY1 expression and subsequent nuclear translocation were upregulated in a glucose- and time-dependent manner via the mTORC1/p70S6K signaling pathway in HK-2 cells. YY1 expression and nuclear translocation was significantly upregulated in db/db mice. Furthermore, YY1 upregulated α-SMA expression and activity in high-glucose-cultured HK-2 cells. Overexpression of YY1 promoted renal fibrosis in db/m mice mainly by upregulating α-SMA expression and inducing epithelial-mesenchymal transition (EMT) in vitro and in vivo. Finally, downregulation of YY1 reversed renal fibrosis by improving EMT in vivo and in vitro.
CONCLUSIONS: These results reveal that upregulation of YY1 plays a critical role in HG-induced deregulation of EMT-associated protein expression, which finally results in renal fibrosis of DN. Therefore, decreasing YY1 expression might represent a new therapeutic target for diabetic nephropathy-induced renal fibrosis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Epithelial-mesenchymal transition; Renal fibrosis; YY1; α-SMA

Year:  2019        PMID: 31028762     DOI: 10.1016/j.metabol.2019.04.013

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Impact of Diabetic Nephropathy on Pulmonary Function and Clinical Outcomes.

Authors:  Chunbo Niu; Lu Liu; Yang Li; Xiaoqi Li
Journal:  Comput Intell Neurosci       Date:  2022-08-28

2.  MiR-195 inhibits the ubiquitination and degradation of YY1 by Smurf2, and induces EMT and cell permeability of retinal pigment epithelial cells.

Authors:  Shu-Hua Fu; Mei-Chen Lai; Yun-Yao Zheng; Ya-Wen Sun; Jing-Jing Qiu; Fu Gui; Qian Zhang; Fei Liu
Journal:  Cell Death Dis       Date:  2021-07-15       Impact factor: 8.469

3.  LncRNA LINC00668 promotes cell proliferation, migration, invasion ability and EMT process in hepatocellular carcinoma by targeting miR-532-5p/YY1 axis.

Authors:  Wei Xuan; Chen Zhou; Guangqiang You
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

4.  LINC00842 inactivates transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodelling.

Authors:  Xudong Huang; Ling Pan; Zhixiang Zuo; Mei Li; Lingxing Zeng; Rui Li; Ying Ye; Jialiang Zhang; Guandi Wu; Ruihong Bai; Lisha Zhuang; Lusheng Wei; Yanfen Zheng; Jiachun Su; Junge Deng; Shuang Deng; Shaoping Zhang; Shihao Zhu; Xu Che; Chengfeng Wang; Chen Wu; Rufu Chen; Dongxin Lin; Jian Zheng
Journal:  Nat Commun       Date:  2021-06-22       Impact factor: 14.919

Review 5.  Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease.

Authors:  Claudia Tovar-Palacio; Lilia G Noriega; Adriana Mercado
Journal:  Nutrients       Date:  2022-02-03       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.